Efficacy and Safety of JT001 (VV116) Compared With Paxlovid
Clinical trial NCT05341609 · COMPLETED
Trial details
- NCT number
- NCT05341609
- Sponsor
- Vigonvita Life Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-04
- Primary completion
- 2022-05-13
- Enrollment
- 822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.